Clinical Trials Browser

Phase 1/2 × INDUSTRY × Histone Deacetylase Inhibitors × Clear all

NCT00792467 2021-05-11

Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma

Phase 1/2 Completed

24 enrolled 13 charts

Hodgkin Disease